Table 2.
Optimal adherence after monitoring 1 (M1) and monitoring 2 (M2
| Total (n = 483) | In-person (n = 193) | Online (n = 144) | App (n = 84) | Standard care (n = 62) | p value* | |
|---|---|---|---|---|---|---|
| ≥ 90% adherence during both follow-ups | 363 (75.2) | 151 (78.4%) | 112 (77.8) | 58 (69.0) | 42 (67.7) | 0.165 |
| < 90% at M1: | 120 (24.8) | 42 (21.8) | 32 (22.2) | 26 (31.0) | 20 (32.3) | 0.087 |
|
Same therapy adherence (± 5%) |
31 (25.8) | 10 (23.8) | 6 (18.8) | 9 (34.6) | 6 (30.0) | |
| > 5% increased | 47 (39.2) | 23 (54.8) | 12 (37.5) | 7 (26.9) | 5 (25.0) | |
| > 5% decreased | 42 (35.0) | 9 (21.4) | 14 (43.8) | 10 (38.5) | 9 (45.0) |
*Chi-square test